Related Experiment Video
Updated: Sep 18, 2025
04:15
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
2.0K
Introduction to special section: Treatment of antagonism
1Psychology Department, University of Kentucky.
Personality Disorders
|June 26, 2025
Summary
This special section addresses antagonism treatment in clinical psychology. It highlights inadequate training and offers intervention program suggestions for improved patient care.
Area of Science:
- Psychology
- Clinical Psychology
- Personality Disorders
Background:
- Focuses on the dimensional trait domain of antagonism within personality disorders.
- Introduces a special section dedicated to the treatment of antagonism.
- Highlights a target article addressing insufficient training in antagonism treatment.
Discussion:
- Examines the current state of clinical psychology training regarding antagonism.
- Presents four invited commentaries offering solutions.
- Discusses potential intervention programs for enhancing treatment efficacy.
Key Insights:
- There is a recognized deficit in training for antagonism treatment.
- Commentaries provide actionable strategies for intervention.
- The special section aims to bridge the gap between theory and practice.
Outlook:
- Aims to improve the training and treatment of antagonism.
- Encourages further research into effective intervention programs.
- Contributes to the broader understanding and management of personality disorders.
Related Concept Videos
01:30Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
01:14Agonism and Antagonism: Quantification
586
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
586
01:28Drug-Receptor Interaction: Antagonist
3.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.5K
01:26Cholinergic Antagonists: Therapeutic Uses
884
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
884
01:29Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.1K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.1K